Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Infinitopes logo — Advancing immune defenses to prevent metastases and save liv...

Infinitopes

Advancing immune defenses to prevent metastases and save lives with innovative therapy designs and precise tumor targeting.

Founded 2021 11-50 employees Seed Total: $12.80M Biotechnology

General Information

Company Name Infinitopes
Founded Year 2021
Employees 11-50
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Infinitopes. To contact Infinitopes, visit infinitopes.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Infinitopes

Infinitopes is a biotechnology startup founded in 2021, dedicated to advancing immune defenses to prevent metastases and save lives. The company's slogan, "Advancing immune defenses to prevent metastases and save lives with innovative therapy designs and precise tumor targeting," encapsulates its mission. Infinitopes is at the forefront of developing advanced healthcare systems and therapeutic designs, with a focus on high-efficiency vector delivery systems and optimal tumor target identification technologies. These innovations are currently in early-stage clinical trials and have the potential to empower patients to prevent cancer and tumors from threatening their lives. The latest milestone in the company's journey is its Venture Round investment at 01 January 2024, with Manta Ray as the lead investor. This investment not only signifies confidence in Infinitopes' vision and capabilities but also provides the necessary financial support for the startup's continued growth and development. As the company continues to make strides in the biotechnology industry, its strong focus on leveraging cutting-edge technology for combating metastases is likely to draw further attention from potential partners and investors. With its promising approach and innovative solutions, Infinitopes is poised to make valuable contributions to the biotechnology sector. As the company progresses in its mission to enhance immune defenses and combat metastases, it represents an intriguing prospect for investors seeking opportunities in the healthcare and biotechnology space.

Taxonomy: cancer research, immune system, metastases prevention, therapeutic designs, healthcare systems, high-efficiency vector delivery systems, tumor targeting technologies, clinical trials, cancer prevention, immune defense advancement

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £12.80M 10
Kindred Capital Octopus Ventures Martlet Capital
Kindred Capital, Octopus Ventures +8
30 Apr 2024

Latest News

View All
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown — Sifted
April’s early-stage funding wrapup: Big month for healthtech and UK maintains its crown
Sifted May 10, 2024

Infinitopes Alternatives & Competitors

View All Alternatives
Infinitopes vs
Acomhal Research, Inc.
Acomhal Research, Inc. United States

Providing novel and effective therapeutic approaches to prevent tumor recurrence and metastasis

Grant
2 employees
Biotechnology, Health Care
Infinitopes vs
OncoTrap
OncoTrap

Pioneering the future of cancer treatment by harnessing the power of the immune system to eradicate...

Grant
Biotechnology
Infinitopes vs
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH Germany

Abalos is harnessing the power of arenaviruses in a differentiated immuno-virotherapy approach to fi...

23 employees
Biotechnology
View all alternatives

FAQ About Infinitopes

Advancing immune defenses to prevent metastases and save lives with innovative therapy designs and precise tumor targeting.
Infinitopes was founded in 2021.
Infinitopes operates in Biotechnology. Its work centres on cancer research, immune system, metastases prevention and therapeutic designs.
Infinitopes has approximately 11-50 employees.
Infinitopes has completed 1 funding round, raising a total of $12.80M. The latest funding stage is Seed.
Top alternatives and competitors to Infinitopes include Acomhal Research, Inc., OncoTrap, Abalos Therapeutics GmbH, Intensity Therapeutics, Inc., HRAIN BIOTECHNOLOGY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Infinitopes and Acomhal Research, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Infinitopes, https://bouncewatch.com/company/infinitopes, updated 1 August 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes